Skip to main content
Top
Published in: Calcified Tissue International 1/2004

01-07-2004

Dual X-ray Absorptiometry: Cross-Calibration of a New Fan-Beam System

Authors: G. M. Blake, E. J. Harrison, J. E. Adams

Published in: Calcified Tissue International | Issue 1/2004

Login to get access

Abstract

The high precision and stable calibration of dual X-ray absorptiometry (DXA) scanners have led to their widespread use in longitudinal studies for research and the follow-up of individual patients who are receiving treatment for osteoporosis. However, difficulties in maintaining the continuity of the bone mineral density (BMD) calibration scale can arise when an old DXA system is replaced by a newer model. We report the results of an in vivo cross-calibration study performed when a GE-Lunar Prodigy fan-beam system replaced a DPX-L pencil-beam scanner. Lumbar spine and hip DXA scans were performed in 133 patients (104 female, 29 male) attending long-term BMD monitoring. On average, lumbar spine BMD measurements on the two systems agreed closely, with Prodigy values 1% lower than those on the DPX-L. However, after allowing for this difference, the root mean square error (RMSE) of 0.037 g/cm2 was larger than in previous cross-calibration studies reported in the literature, and was 3 times the value expected from the precision of the BMD measurements. Mean femoral neck BMD also agreed closely between the two systems, although for Prodigy, the spread of measurements was 10% smaller than that for the DPX-L. For the trochanter and Ward’s triangle regions, mean BMD was 4% and 6% lower, respectively, on the Prodigy system, and the results were affected by a similar compression of the range of values. RMSE values were 0.037 g/cm2, 0.044 g/cm2, and 0.044 g/cm2, respectively, for the femoral neck, trochanter, and Ward’s triangle sites. When the high value of the RMSE was investigated, it was found that for lumbar spine BMD, patient body weight and the difference between the two systems in the percentage fat reported in the soft tissue reference region explained 40% of the variance. This enabled equations to be developed that significantly improved the agreement between scans performed on the two systems. Smaller improvements were obtained for the femur BMD measurements.
Literature
1.
go back to reference Genant, HK, Engelke, K, Fuerst, T 1996Noninvasive assessment of bone mineral and structure: state of the art. J Bone Miner Res11707730PubMed Genant, HK, Engelke, K, Fuerst, T 1996Noninvasive assessment of bone mineral and structure: state of the art. J Bone Miner Res11707730PubMed
2.
go back to reference Baran, DT, Faulkner, KG, Genant, HK 1997Diagnosis and management of osteoporosis: guidelines for the utilization of bone densitometry.Calcif Tissue Int61433440CrossRefPubMed Baran, DT, Faulkner, KG, Genant, HK 1997Diagnosis and management of osteoporosis: guidelines for the utilization of bone densitometry.Calcif Tissue Int61433440CrossRefPubMed
3.
go back to reference Kanis, JA Delmas, P Burckhardt, P Cooper, C Torgerson, D on behalf of the European Foundation for Osteoporosis and Bone Disease1997Guidelines for diagnosis and treatment of osteoporosis.Osteoporos Int7390406PubMed Kanis, JA Delmas, P Burckhardt, P Cooper, C Torgerson, D on behalf of the European Foundation for Osteoporosis and Bone Disease1997Guidelines for diagnosis and treatment of osteoporosis.Osteoporos Int7390406PubMed
4.
go back to reference Kanis, JA, Glüer, C-C 2000An update on the diagnosis and assessment of osteoporosis with densitometry.Osteoporos Int11192202CrossRefPubMed Kanis, JA, Glüer, C-C 2000An update on the diagnosis and assessment of osteoporosis with densitometry.Osteoporos Int11192202CrossRefPubMed
5.
go back to reference Cooper, C, Campion, G, Melton, LJ 1992Hip fractures in the elderly: a world-wide projection.Osteoporos Int2285289PubMed Cooper, C, Campion, G, Melton, LJ 1992Hip fractures in the elderly: a world-wide projection.Osteoporos Int2285289PubMed
6.
go back to reference Schurch, M-A, Rizzoli, R, Mermillod, B, Vasey, H, Michel, JP, Bonjour, J-P 1996A prospective study on socio-economic aspects of fracture of the proximal femur.Bone Miner Res1119351942 Schurch, M-A, Rizzoli, R, Mermillod, B, Vasey, H, Michel, JP, Bonjour, J-P 1996A prospective study on socio-economic aspects of fracture of the proximal femur.Bone Miner Res1119351942
7.
go back to reference Ray, NF, Chan, JK, Thamer, M, Melton, LJ 1997Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation.J Bone Miner Res122435PubMed Ray, NF, Chan, JK, Thamer, M, Melton, LJ 1997Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation.J Bone Miner Res122435PubMed
8.
go back to reference Black, DM, Cummings, SR, Karpf, DB 1996Randomised trial of the effect of alendronate on risk of fracture in women with existing vertebral fractures.Lancet34815351541CrossRefPubMed Black, DM, Cummings, SR, Karpf, DB 1996Randomised trial of the effect of alendronate on risk of fracture in women with existing vertebral fractures.Lancet34815351541CrossRefPubMed
9.
go back to reference Ettinger, B, Black, DM, Mitlak, BH 1999Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial.JAMA282637645CrossRefPubMed Ettinger, B, Black, DM, Mitlak, BH 1999Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial.JAMA282637645CrossRefPubMed
10.
go back to reference Harris, ST, Watts, NB, Genant, HK 1999Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis.JAMA28213441352CrossRefPubMed Harris, ST, Watts, NB, Genant, HK 1999Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis.JAMA28213441352CrossRefPubMed
11.
go back to reference Neer, RM, Arnaud, CD, Zanchetta, JR 2001Effect of recombinant human parathyroid hormone (1-34) fragment on spine and non-spine fractures and bone mineral density in postmenopausal osteoporosis.N Engl J Med34414341441CrossRefPubMed Neer, RM, Arnaud, CD, Zanchetta, JR 2001Effect of recombinant human parathyroid hormone (1-34) fragment on spine and non-spine fractures and bone mineral density in postmenopausal osteoporosis.N Engl J Med34414341441CrossRefPubMed
12.
go back to reference Royal College of Physicians1999Osteoporosis: clinical guidelines for prevention and treatment.RCPLondon, England Royal College of Physicians1999Osteoporosis: clinical guidelines for prevention and treatment.RCPLondon, England
13.
go back to reference WHO Technical Report Series 8431994Assessment of fracture risk and its application to screening for postmenopausal osteoporosis.World Health OrganizationGeneva WHO Technical Report Series 8431994Assessment of fracture risk and its application to screening for postmenopausal osteoporosis.World Health OrganizationGeneva
14.
go back to reference Royal College of Physicians2000Osteoporosis: clinical guidelines for prevention and treatment. Update on pharmacological interventions and an algorithm for management.RCPLondon, England Royal College of Physicians2000Osteoporosis: clinical guidelines for prevention and treatment. Update on pharmacological interventions and an algorithm for management.RCPLondon, England
16.
go back to reference Liberman, UA, Weiss, SR, Bröll, J 1995Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis.N Engl J Med33314371443CrossRefPubMed Liberman, UA, Weiss, SR, Bröll, J 1995Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis.N Engl J Med33314371443CrossRefPubMed
17.
go back to reference Tonino, RP, Meunier, PJ, Emkey, R 2000Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women.J Clin Endocrinol Metab8531093115CrossRefPubMed Tonino, RP, Meunier, PJ, Emkey, R 2000Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women.J Clin Endocrinol Metab8531093115CrossRefPubMed
18.
go back to reference Cummings, SR, Black, DM, Thompson, DE 1998Effect of alendronate on risk of fracture in women with low bone density but without vertebral fracture: results from the Fracture Intervention Trial.JAMA28020772082CrossRefPubMed Cummings, SR, Black, DM, Thompson, DE 1998Effect of alendronate on risk of fracture in women with low bone density but without vertebral fracture: results from the Fracture Intervention Trial.JAMA28020772082CrossRefPubMed
19.
go back to reference Reginster, J-Y, Minne, HW, Sorensen, OH 2000Randomised trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis.Osteoporos Int118391CrossRefPubMed Reginster, J-Y, Minne, HW, Sorensen, OH 2000Randomised trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis.Osteoporos Int118391CrossRefPubMed
20.
go back to reference Chesnut, CH, Silverman, S, Andriano, K 2000A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study.Am J Med109267276CrossRefPubMed Chesnut, CH, Silverman, S, Andriano, K 2000A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study.Am J Med109267276CrossRefPubMed
21.
go back to reference McClung, MR, Geusens, P, Miller, PD 2001Effect of risedronate treatment on hip fracture risk in elderly women.N Engl J Med344333340CrossRefPubMed McClung, MR, Geusens, P, Miller, PD 2001Effect of risedronate treatment on hip fracture risk in elderly women.N Engl J Med344333340CrossRefPubMed
22.
go back to reference Reid, IR, Brown, JP, Burckhardt, P 2002Intravenous zolendronic acid in postmenopausal women with low bone mineral density.N Engl J Med346653661CrossRefPubMed Reid, IR, Brown, JP, Burckhardt, P 2002Intravenous zolendronic acid in postmenopausal women with low bone mineral density.N Engl J Med346653661CrossRefPubMed
23.
go back to reference Gluer, C-C, Faulkner, KG, Estilo, MJ, Engelke, K, Rosin, J, Genant, HK 1993Quality assurance for bone densitometry research studies: concept and impact.Osteoporos Int3227235PubMed Gluer, C-C, Faulkner, KG, Estilo, MJ, Engelke, K, Rosin, J, Genant, HK 1993Quality assurance for bone densitometry research studies: concept and impact.Osteoporos Int3227235PubMed
24.
go back to reference Faulkner, KG, McClung, MR 1995Quality control of DXA instruments in multicenter trials.Osteoporos Int5218227PubMed Faulkner, KG, McClung, MR 1995Quality control of DXA instruments in multicenter trials.Osteoporos Int5218227PubMed
25.
go back to reference Genant, HK, Grampp, S, Glüer, C-C 1994Universal standardization for dual X-ray absorptiometry: patient and phantom cross-calibration results.J Bone Miner Res915031514 Genant, HK, Grampp, S, Glüer, C-C 1994Universal standardization for dual X-ray absorptiometry: patient and phantom cross-calibration results.J Bone Miner Res915031514
26.
go back to reference Faulkner, KG, Gluer, C-C, Estilo, MJ, Genant, HK 1993Cross-calibration of DXA equipment: upgrading from a Hologic QDR-1000/W to a QDR-2000.Calcif Tissue Int527984PubMed Faulkner, KG, Gluer, C-C, Estilo, MJ, Genant, HK 1993Cross-calibration of DXA equipment: upgrading from a Hologic QDR-1000/W to a QDR-2000.Calcif Tissue Int527984PubMed
27.
go back to reference Blake, GM, Parker, JC, Buxton, FMA, Fogelman, I 1993Dual X-ray absorptiometry: a comparison between fan beam and pencil beam scans.Br J Radiol66902906PubMed Blake, GM, Parker, JC, Buxton, FMA, Fogelman, I 1993Dual X-ray absorptiometry: a comparison between fan beam and pencil beam scans.Br J Radiol66902906PubMed
28.
go back to reference Mazess, RB, Collick, B, Trempe, J, Barden, HS, Hanson, JA 1989Performance evaluation of a dual-energy X-ray bone densitometer.Calcif Tissue Int44228232PubMed Mazess, RB, Collick, B, Trempe, J, Barden, HS, Hanson, JA 1989Performance evaluation of a dual-energy X-ray bone densitometer.Calcif Tissue Int44228232PubMed
29.
go back to reference Mazess, RB, Hanson, JA, Payne, R, Nord, R, Wilson, M 2000Axial and total-body bone densitometry using a narrow-angle fan-beam.Osteoporos Int11158166PubMed Mazess, RB, Hanson, JA, Payne, R, Nord, R, Wilson, M 2000Axial and total-body bone densitometry using a narrow-angle fan-beam.Osteoporos Int11158166PubMed
30.
go back to reference Kalender, WA, Felsenberg, D, Genant, HK, Fischer, M, Dequeker, J, Reeve, J 1995The European Spine Phantom—a tool for standardization and quality control in spinal bone mineral measurements by DXA and OCT.Eur J Radiol208392CrossRefPubMed Kalender, WA, Felsenberg, D, Genant, HK, Fischer, M, Dequeker, J, Reeve, J 1995The European Spine Phantom—a tool for standardization and quality control in spinal bone mineral measurements by DXA and OCT.Eur J Radiol208392CrossRefPubMed
31.
go back to reference Mazess, RB, Tempe, JA, Bisek, JP, Hanson, JA 1991Calibration of dual-energy X-ray absorptiometry (DEXA) for bone density.J Bone Miner Res6799806PubMed Mazess, RB, Tempe, JA, Bisek, JP, Hanson, JA 1991Calibration of dual-energy X-ray absorptiometry (DEXA) for bone density.J Bone Miner Res6799806PubMed
32.
go back to reference Hanson, J 1997Standardization of femur BMD [letter].J Bone Miner Res1213161317PubMed Hanson, J 1997Standardization of femur BMD [letter].J Bone Miner Res1213161317PubMed
33.
go back to reference Altman, DG 1991Practical statistics for medical research.Chapman HallLondon Altman, DG 1991Practical statistics for medical research.Chapman HallLondon
34.
go back to reference Blake, GM 1996Replacing DXA scanners: cross-calibration with phantoms may be misleading.Calcif Tissue Int5915CrossRef Blake, GM 1996Replacing DXA scanners: cross-calibration with phantoms may be misleading.Calcif Tissue Int5915CrossRef
35.
go back to reference Blake, GM, Fogelman, I 1995Replacing dual X-ray absorptiometry scanners: cross-calibration of a new multidetector array.J Bone Miner Res10S267 Blake, GM, Fogelman, I 1995Replacing dual X-ray absorptiometry scanners: cross-calibration of a new multidetector array.J Bone Miner Res10S267
36.
go back to reference Steel, SA, Thorpe, J 2002The GE-Lunar Prodigy: in vivo precision and cross-calibration.Calcif Tissue Int71277278 Steel, SA, Thorpe, J 2002The GE-Lunar Prodigy: in vivo precision and cross-calibration.Calcif Tissue Int71277278
37.
go back to reference Bolotin, HH, Sievanen, H, Grashuis, JL, Kuiper, JW, Jarvinen, TLN 2001Inaccuracies inherent in patient-specific dual-energy X-ray absorptiometry bone mineral density measurements: comprehensive phantom-based evaluation.J Bone Miner Res16417426PubMed Bolotin, HH, Sievanen, H, Grashuis, JL, Kuiper, JW, Jarvinen, TLN 2001Inaccuracies inherent in patient-specific dual-energy X-ray absorptiometry bone mineral density measurements: comprehensive phantom-based evaluation.J Bone Miner Res16417426PubMed
38.
go back to reference Wilson, CR, Carrera, GF, Bergersen, J 2002The effect of patient weight on BMD measurement precision.Calcif Tissuer Int71281282 Wilson, CR, Carrera, GF, Bergersen, J 2002The effect of patient weight on BMD measurement precision.Calcif Tissuer Int71281282
Metadata
Title
Dual X-ray Absorptiometry: Cross-Calibration of a New Fan-Beam System
Authors
G. M. Blake
E. J. Harrison
J. E. Adams
Publication date
01-07-2004
Publisher
Springer-Verlag
Published in
Calcified Tissue International / Issue 1/2004
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-004-0169-y

Other articles of this Issue 1/2004

Calcified Tissue International 1/2004 Go to the issue

Announcements

Announcements

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine